Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF618 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEBPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LIF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM83A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKIRAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM131B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on